Prognostic Stage III Breast Cancer AJCC v8 Recruiting Phase 2 Trials for Sargramostim (DB00020)

Also known as: Prognostic Stage 3 Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0109635 (Prognostic Stage III Breast Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05455658STEMVAC in Patients With Early Stage Triple Negative Breast CancerPrevention